PURPOSE In specialist care, fecal calprotectin (FCal) is a commonly used noninvasive diagnostic test for ruling out inflammatory bowel disease (IBD) in children with chronic gastrointestinal symptoms. The aim of this study was to evaluate the diagnostic accuracy of FCal for IBD in symptomatic children in primary care.
METHODSWe studied 2 prospective cohorts of children with chronic diarrhea, recurrent abdominal pain, or both: children initially seen in primary care (primary care cohort) and children referred to specialist care (referred cohort). FCal (index test) was measured at baseline and compared with 1 of the 2 reference standards for IBD: endoscopic assessment or 1-year follow-up. Physicians were blinded to FCal results, and values greater than 50 μg/g feces were considered positive. We determined specificity in the primary care cohort and sensitivity in the referred cohort.
RESULTSNone of the 114 children in the primary care cohort ultimately received a diagnosis of IBD. The specificity of FCal in the primary care cohort was 0.87 (95% CI, 0.80-0.92). Among the 90 children in the referred cohort, 17 (19%) ultimately received a diagnosis of IBD. The sensitivity of FCal in the referred cohort was 0.99 (95% CI, 0.81-1.00).CONCLUSIONS The findings of this study suggest that a positive FCal result in children with chronic gastrointestinal symptoms seen in primary care is not likely to be indicative of IBD. A negative FCal result is likely to be a true negative, which safely rules out IBD in children in whom a primary care physician considers referral to specialist care. 2016;14:437-445. doi: 10.1370/afm.1949.
Ann Fam Med
INTRODUCTIONP rimary care physicians frequently manage recurrent abdominal pain or diarrhea in children. These symptoms account for approximately 2% to 5% of all childhood consultations.1-3 Although they are typically functional in origin, it is essential that organic disease be ruled out. Inflammatory bowel disease (IBD), that is, Crohn disease and ulcerative colitis, is an organic disease that primary care physicians should not miss. Delay in diagnosing IBD, and the resultant delay in receipt of appropriate treatment, may prolong suffering and can lead to complications such as anemia, irreversible growth failure, and delayed sexual maturation. 4,5 According to guidelines, primary care physicians should refer children with chronic diarrhea, recurrent abdominal pain, or both for specialist care if red flags are present. 6,7 The red flags are nonspecific and discriminate poorly between functional and organic gastrointestinal diseases, [8][9][10] often leading to referral and extensive diagnostic testing. For children with functional disorders, referral or extensive testing may delay appropriate interventions and further decrease well-being. 11,12 Calprotectin is a calcium-binding protein released from neutrophils during intestinal inflammation that can be easily measured in feces. 13,14 In specialist care, evidence shows it to be a useful, simple, noninvasive test
438that can rule out ...